RI(dl)-2 is a selective inhibitor of Rad51-mediated D-loop formation. References: Mongraw-Chaffin M, LaCroix AZ, Sears DD, Garcia L, Phillips LS, Salmoirago-Blotcher E, Zaslavsky O, Anderson CA. A prospective study of low fasting glucose with cardiovascular disease events and all-cause mortality: The Women's Health Initiative. Metabolism. 2017 May;70:116-124. doi: 10.1016/j.metabol.2017.02.010. Epub 2017 Feb 16. PubMed PMID: 28403935; PubMed Central PMCID: PMC5402725.

纯度：≥98%

CAS：1902146-75-1